Glucotrack, Inc. Files 8-K with Financials
Ticker: GCTK · Form: 8-K · Filed: Jan 30, 2025 · CIK: 1506983
Sentiment: neutral
Topics: financial-statements, disclosure
Related Tickers: GCTK
TL;DR
Glucotrack (GCTK) filed an 8-K on Jan 30, 2025, with financial statements and disclosures.
AI Summary
Glucotrack, Inc. filed an 8-K on January 30, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Integrity Applications, Inc., is incorporated in Delaware and headquartered in Rutherford, NJ.
Why It Matters
This filing provides updated financial information and disclosures for Glucotrack, Inc., which is crucial for investors to assess the company's current financial health and operational status.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate operational or financial distress.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former company name
- January 30, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Rutherford, NJ (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Glucotrack, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
When was this 8-K report filed by Glucotrack, Inc.?
This 8-K report was filed on January 30, 2025.
What were Glucotrack, Inc.'s previous names?
Glucotrack, Inc. was formerly known as GlucoTrack, Inc. (since March 28, 2022) and prior to that, Integrity Applications, Inc. (since December 3, 2010).
Where are Glucotrack, Inc.'s principal executive offices located?
Glucotrack, Inc.'s principal executive offices are located at 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
In which state is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in Delaware.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-30 08:38:57
Key Financial Figures
- $0.001 — f the Company's common stock, par value $0.001 per share. The Press Release is furnish
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-25-004216.txt ( ) — 241KB
- gctk-20250130.xsd (EX-101.SCH) — 3KB
- gctk-20250130_lab.xml (EX-101.LAB) — 33KB
- gctk-20250130_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 30, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer